Who is the CEO of RNAC? | Glauxie AI

Q: Who is the CEO of RNAC?

Cartesian Therapeutics, Inc. (RNAC) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Carsten Brunn. Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human... Employees: 75.

Q: What does RNAC company do?

Learn what RNAC does — business model, products, services, revenue segments, and company history.

Q: Are insiders buying or selling RNAC?

Track recent insider buys and sells for RNAC with transaction details, amounts, and trends.

Q: What sector is RNAC in?

Find RNAC sector, industry, and sub-industry classification with sector peer comparison.

Who is the CEO of RNAC?

🦉

Cartesian Therapeutics, Inc. (RNAC)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOCarsten Brunn

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in Phase I clinical trial...

Key Executives

Name	Title
Blaine T. Davis	Chief Financial Officer
Carsten Brunn	President, Chief Executive Officer & Chairman of the Board
Emily English	Chief Operating Officer
June Seymour	Chief Accounting Officer
Matthew Bartholomae	General Counsel & Secretary
Metin Kurtoglu	Consultant

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

RNAC Profile Financials

What does RNAC company do? Are insiders buying or selling RNAC? What sector is RNAC in?